PharVision Advisers LLC Invests $561,000 in Nu Skin Enterprises, Inc. (NYSE:NUS)

PharVision Advisers LLC bought a new position in Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 81,429 shares of the company's stock, valued at approximately $561,000. Nu Skin Enterprises comprises approximately 0.5% of PharVision Advisers LLC's holdings, making the stock its 28th largest holding. PharVision Advisers LLC owned approximately 0.16% of Nu Skin Enterprises as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Meeder Asset Management Inc. purchased a new position in Nu Skin Enterprises in the 4th quarter worth approximately $25,000. US Bancorp DE raised its stake in shares of Nu Skin Enterprises by 424.2% in the fourth quarter. US Bancorp DE now owns 7,460 shares of the company's stock worth $51,000 after purchasing an additional 6,037 shares during the last quarter. Signaturefd LLC lifted its holdings in shares of Nu Skin Enterprises by 536.8% during the fourth quarter. Signaturefd LLC now owns 8,087 shares of the company's stock valued at $56,000 after purchasing an additional 6,817 shares in the last quarter. PNC Financial Services Group Inc. lifted its holdings in shares of Nu Skin Enterprises by 2,412.2% during the fourth quarter. PNC Financial Services Group Inc. now owns 8,215 shares of the company's stock valued at $57,000 after purchasing an additional 7,888 shares in the last quarter. Finally, Bank of Montreal Can purchased a new stake in shares of Nu Skin Enterprises during the fourth quarter valued at $80,000. Institutional investors own 82.84% of the company's stock.

Nu Skin Enterprises Stock Performance

NYSE:NUS traded down $0.06 during trading hours on Monday, reaching $7.26. The company had a trading volume of 592,343 shares, compared to its average volume of 834,065. The firm has a market cap of $358.74 million, a price-to-earnings ratio of -2.46 and a beta of 0.92. The company has a current ratio of 1.82, a quick ratio of 1.17 and a debt-to-equity ratio of 0.56. The firm's 50 day moving average price is $6.60 and its 200-day moving average price is $7.02. Nu Skin Enterprises, Inc. has a 52 week low of $5.32 and a 52 week high of $13.90.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.15 by $0.08. The firm had revenue of $364.49 million for the quarter, compared to the consensus estimate of $352.06 million. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. On average, analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current year.

Nu Skin Enterprises Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 11th. Stockholders of record on Friday, May 30th will be paid a $0.06 dividend. This represents a $0.24 annualized dividend and a dividend yield of 3.31%. The ex-dividend date of this dividend is Friday, May 30th. Nu Skin Enterprises's dividend payout ratio (DPR) is presently -30.00%.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded shares of Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research note on Monday, May 12th.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.